Loading…
Import this data to Google Sheets with:
=jivedata("DXPRV","financials")Full statements spill as a table. For one cell: =jivedata("DXPRV","Revenue") or =jivedata("DXPRV","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
DXPRV • CIK 0000826675
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 |
|---|
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $119,639 | $377,099 | $531,043 | $607,562 |
| Restricted Cash and Cash Equivalents | $118,225 | $244,440 | $399,344 | $570,020 |
| Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value | $6,038,948 | $7,512,087 | $16,306,988 | $25,066,198 |
| Receivables from Brokers-Dealers and Clearing Organizations | $1,313 | $10,445 | $17,425 | $53,446 |
| Derivative Asset | $54,361 | $133 | $10,498 | $8,441 |
| Interest Receivable | $28,727 | $32,841 | $67,940 | $104,272 |
| Prepaid Expense and Other Assets | $8,537 | $7,534 | $8,940 | $9,663 |
| Assets | $6,369,750 | $8,184,579 | $17,342,178 | $26,419,602 |
| Securities Sold under Agreements to Repurchase | $5,381,104 | $6,563,120 | $13,904,231 | $22,644,742 |
| Other Payables to Broker-Dealers and Clearing Organizations | $95 | $341,924 | $811,656 | $380,947 |
| Derivative Liability | $0 | $22,814 | $4,830 | $9,117 |
| Interest Payable | $53,194 | $44,672 | $95,196 | $135,194 |
| Dividends Payable | $10,320 | $16,501 | $37,171 | $46,943 |
| Other Liabilities | $8,301 | $10,612 | $18,577 | $12,092 |
| Liabilities | $5,499,015 | $6,999,643 | $14,880,034 | $23,244,535 |
| Preferred Stock, Value, Outstanding | $107,843 | $107,843 | $107,843 | $107,843 |
| Common Stock, Value, Outstanding | $570 | $845 | $1,748 | $2,374 |
| Additional Paid in Capital, Common Stock | $1,404,431 | $1,742,471 | $2,921,551 | $3,760,123 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-158,502 | $-172,489 | $-127,061 | $-128,074 |
| Retained Earnings (Accumulated Deficit) | $-483,607 | $-493,734 | $-441,937 | $-567,199 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $870,735 | $1,184,936 | $2,462,144 | $3,175,067 |
| Preferred Stock, Shares Authorized | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| Preferred Stock, Shares Outstanding | 4,460,000 | 4,460,000 | 4,460,000 | 4,460,000 |
| Preferred Stock, Liquidation Preference, Value | $111,500 | $111,500 | $111,500 | $111,500 |
| Common Stock, Shares Authorized | 180,000,000 | 180,000,000 | 360,000,000 | 720,000,000 |
| Common Stock, Shares, Issued | 57,038,247 | 84,491,800 | 174,814,912 | 237,414,259 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $-212,013 | $383,675 | $308,848 | $471,745 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $237,864 | $621,539 | $930,387 | $1,632,017 |
| Net Income (Loss) Attributable to Parent | $-6,130 | $113,898 | $319,066 | $436,177 |
| Net Cash Provided by (Used in) Operating Activities | $62,200 | $14,392 | $120,821 | $236,576 |
| Payments to Acquire Trading Securities Held-for-investment | $3,578,289 | $1,872,422 | $8,882,183 | $17,461,300 |
| Proceeds from Maturities, Repayments and Calls of Debt Securities, FV-NI, Held-for-investment | $233,387 | $439,900 | $832,872 | $1,593,218 |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $86,272 | $75,024 | $119,851 | $76,857 |
| Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | $348,091 | $13,782 | $0 | $633,301 |
| Proceeds from Principal Repayments on Loans and Leases Held-for-investment | $889 | $762 | $549 | $450 |
| Payments for (Proceeds from) Derivative Instrument, Investing Activities | $95,968 | $-362,929 | $153,439 | $-250,606 |
| Increase (Decrease) Cash Collateral from Counterparties | $45,566 | $-46,001 | $8,373 | $-13,823 |
| Net Cash Provided by (Used in) Investing Activities | $-2,960,052 | $-1,026,026 | $-8,073,977 | $-14,920,691 |
| Proceeds from Short-term Debt | — | — | $143,887,928 | $197,253,555 |
| Repayments of Short-term Debt | — | — | $136,546,817 | $183,208,956 |
| Proceeds from Issuance of Common Stock | $42,626 | $332,317 | $1,169,278 | $1,480,477 |
| Payments of Stock Issuance Costs | $0 | $231 | $157 | $277 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $445 | $949 | $1,629 | $4,592 |
| Payments of Dividends | $93,041 | $117,844 | $246,599 | $364,347 |
| Net Cash Provided by (Used in) Financing Activities | $2,685,839 | $1,395,309 | $8,262,004 | $15,155,860 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $178,705 | $322,179 | $368,641 | $565,385 |
| Noncash or Part Noncash Acquisition, Investments Acquired | — | — | $809,201 | $251,432 |
| Debt and Equity Securities, Realized Gain (Loss) | $-74,916 | $-1,506 | $0 | $8,721 |
| Unrealized Gain (Loss) on Investments | $142,501 | $-142,352 | $370,850 | $-50,232 |
| Unrealized Gain (Loss) on Derivatives | $-32,905 | $288,378 | $-113,093 | $296,660 |
| Amortization | $74,696 | $47,671 | $25,967 | $22,143 |
| Other Depreciation and Amortization | $2,315 | $1,867 | $2,098 | $2,233 |
| Share-based Payment Arrangement, Noncash Expense | $4,833 | $7,235 | $12,565 | $17,543 |
| Increase (Decrease) in Accrued Interest Receivable, Net | $13,467 | $3,471 | $35,099 | $60,963 |
| Increase (Decrease) in Interest Payable, Net | $36,744 | $-8,522 | $50,524 | $74,339 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $2,111 | $-234 | $-3,457 | $-253 |